Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002

Emerging Infectious Diseases

Volumn 18, Issue 5, 2012, Pages 741-749

  Tadesse, Daniel A ^a   Zhao, Shaohua ^a   Tong, Emily ^a   Ayers, Sherry ^a   Singh, Aparna ^a   Bartholomew, Mary J ^a   McDermott, Patrick F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE;

ANIMAL FOOD; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; RETROSPECTIVE STUDY; REVIEW; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; CHICKENS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; POULTRY DISEASES; RETROSPECTIVE STUDIES; SWINE; SWINE DISEASES; UNITED STATES;

EID: 84859846278     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1805.111153     Document Type: Review

References (40)

1. Aarestrup FM, Wegener HC, Collignon P. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev Anti Infect Ther. 2008; 6:733-50. http://dx.doi.org/10.1586/14787210.6.5.733
2. Walsh CT. Antibiotics: actions, origins, resistance. Washington (DC): American Society for Microbiology Press; 2003.
3. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004; 10(Suppl):S122-9. http://dx.doi.org/10.1038/nm1145
4. von Baum H, Marre R. Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol. 2005; 295:503-11. http://dx.doi.org/10.1016/j.ijmm.2005.07.002
5. Sodha SV, Lynch M, Wannemuehler K, Leeper M, Malavet M, Schaffzin J, et al. Multistate outbreak of Escherichia coli O157:H7 infections associated with a national fast-food chain, 2006: a study incorporating epidemiological and food source traceback results. Epidemiol Infect. 2011; 139:309-16. http://dx.doi.org/10.1017/S0950268810000920
6. Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis. 2007; 44:769-74. http://dx.doi.org/10.1086/511866
7. Igarashi T, Inatomi J, Wake A, Takamizawa M, Katayama H, Iwata T. Failure of prediarrheal antibiotics to prevent hemolytic uremic syndrome in serologically proven Escherichia coli O157:H7 gastrointestinal infection. J Pediatr. 1999; 135:768-9. http://dx.doi.org/10.1016/S0022-3476(99)70100-9
8. Erb A, Stürmer T, Marre R, Brenner H. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis. 2007; 26:83-90. http://dx.doi.org/10.1007/s10096-006-0248-2
9. Womack NA, Kabera CM, Tong EA, Jones S, Gaines S, Bartholomew M, et al.; The NARMS Working Group. The use of Escherichia coli as a sentinel for antimicrobial resistance in Salmonella. In: Abstracts of the National Foundation for Infectious Diseases Annual Conference on Antimicrobial Resistance, Bethesda, Maryland, February 1-3, 2010. Bethesda (MD): The Foundation; 2010. Abstract no. P12.
10. US Food and Drug Administration. National antimicrobial resistance monitoring system -enteric bacteria (NARMS): 2008 executive report. Rockville (MD); 2010 [cited 2012 Feb 13]. http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/default.htm.
11. Atkinson BA, Lorian V. Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982. J Clin Microbiol. 1984; 20:791-6.
12. Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, Battegay M, et al. Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007. Infection. 2009; 37:534-9. http://dx.doi.org/10.1007/s15010-009-8457-0
13. Kronvall G. Antimicrobial resistance 1979-2009 at Karolinska Hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development. APMIS. 2010; 118:621-39. http://dx.doi.org/10.1111/j.1600-0463.2010.02660.x
14. McEwen SA, Fedorka-Cray P. Antimicrobial use and resistance in animals. Clin Infect Dis. 2002; 34(Suppl 3):S93-106. http://dx.doi.org/10.1086/340246
15. Jensen VF, Jakobsen L, Emborg H, Seyfarth AM, Hammerum AM. Correlation between apramycin and gentamicin use in pigs and an increase reservoir of gentamicin-resistant Escherichia coli. J Antimicrob Chemother. 2006; 58:101-7. http://dx.doi.org/10.1093/jac/dkl201
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; 12th informational supplement. M100-S20. Wayne (PA): The Committee; 2010.
17. Guilfoile P. 2006. Antibiotic resistant bacteria. Northborough (MA): Chelsea House Publishers; 2006.
18. Kunin CM, Atuk N. Excretion of cephaloridine and cephalothin in patients with renal impairment. N Engl J Med. 1966; 274:654-6. http://dx.doi.org/10.1056/NEJM196603242741205
19. Bryskier A. Historical review of antibacterial chemotherapy. In: Bryskier A, editor. Antimicrobial agents: antibacterials and antifungals. Washington (DC): American Society for Microbiology Press; 2005. p. 1-11.
20. Sen PK. Estimates of the regression coeffi cient based on Kendall's tau. J Am Stat Assoc. 1968; 63:1379-89. http://dx.doi.org/10.2307/2285891
21. Salmi T, Määttä A, Anttila P, Ruoho-Airola T, Amnell T. Detecting trends of annual values of atmospheric pollutants by the Mann-Kendall test and Sen's slope estimates: the Excel template application Helsinki: MAKESENS. Helsinki: Finnish Meteorological Institute; 2002.
22. Enne VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. 2001; 357:1325-8. http://dx.doi.org/10.1016/S0140-6736(00)04519-0
23. Kozak GK, Pearl DL, Parkman J, Reid-Smith RJ, Deckert A, Boerlin P. Distribution of sulfonamide resistance genes in Escherichia coli and Salmonella isolates from swine and chickens at abattoirs in Ontario and Québec, Canada. Appl Environ Microbiol. 2009; 75:5999-6001. http://dx.doi.org/10.1128/AEM.02844-08
24. Zhao S, White DG, McDermott PF, Friedman S, English L, Ayers S, et al. Identifi cation and expression of cephamycinase bla (CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother. 2001; 45:3647-50. http://dx.doi.org/10.1128/AAC.45.12.3647-3650.2001
25. Bean DC, Livermore DM, Papa I, Hall LM. Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J Antimicrob Chemother. 2005; 56:962-4. http://dx.doi.org/10.1093/jac/dki332
26. Bean DC, Livermore DM, Hall LM. Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence. Antimicrob Agents Chemother. 2009; 53:1088-93. http://dx.doi.org/10.1128/AAC.00800-08
27. Wu S, Dalsgaard A, Hammerum AM, Porsbo LJ, Jensen LB. Prevalence and characterization of plasmids carrying sulfonamide resistance genes among Escherichia coli from pigs, pig carcasses and human. Acta Vet Scand. 2010; 52:47. http://dx.doi.org/10.1186/1751-0147-52-47
28. Enne VI, Bennett PM, Livermore DM, Hall LM. Enhancement of host fi tness by the sul2-coding plasmid p9123 in the absence of selective pressure. J Antimicrob Chemother. 2004; 53:958-63. http://dx.doi.org/10.1093/jac/dkh217
29. Langlois BE, Cromwell GL, Stahly TS, Dawson KA, Hays VW. Antibiotic resistance of fecal coliforms after long-term withdrawal of therapeutic and subtherapeutic antibiotic use in a swine herd. Appl Environ Microbiol. 1983; 46:1433-4.
30. Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett. 2005; 245:195-203. http://dx.doi.org/10.1016/j.femsle.2005.02.034
31. Schroeder CM, Zhao C, DebRoy C, Torcolini J, Zhao S, White DG, et al. Antimicrobial resistance of Escherichia coli O157 isolated from humans, cattle, swine, and food. Appl Environ Microbiol. 2002; 68:576-81. http://dx.doi.org/10.1128/AEM.68.2.576-581.2002
32. Bischoff KM, White DG, Hume ME, Poole TL, Nisbet DJ. The chloramphenicol resistance gene cmlA is disseminated on transferable plasmids that confer multiple-drug resistance in swine Escherichia coli. FEMS Microbiol Lett. 2005; 243:285-91. http://dx.doi.org/10.1016/j.femsle.2004.12.017
33. White DG, Hudson C, Maurer JJ, Ayers S, Zhao S, Lee MD, et al. Characterization of chloramphenicol and fl orfenicol resistance in Escherichia coli associated with bovine diarrhea. J Clin Microbiol. 2000; 38:4593-8.
34. Schwarz S, Kehrenberg C, Doublet B, Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and fl orfenicol. FEMS Microbiol Rev. 2004; 28:519-42. http://dx.doi.org/10.1016/j.femsre.2004.04.001
35. Cannon M, Harford S, Davies J. A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fl uorinated derivatives. J Antimicrob Chemother. 1990; 26:307-17. http://dx.doi.org/10.1093/jac/26.3.307
36. Harada K, Asai T, Kojima A, Ishihara K, Takahashi T. Role of coresistance in the development of resistance to chloramphenicol in Escherichia coli isolated from sick cattle and pigs. Am J Vet Res. 2006; 67:230-5. http://dx.doi.org/10.2460/ajvr.67.2.230
37. US Food and Drug Administration. 2009 summary report on antimicrobials sold or distributed for use in food-producing animals. December 9, 2010. Rockville, MD [cited 2011Feb 23]. http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm236143.htm
38. Yates CM, Pearce MC, Woolhouse ME, Amyes SG. High frequency transfer and horizontal spread of apramycin resistance in calf faecal Escherichia coli. J Antimicrob Chemother. 2004; 54:534-7. http://dx.doi.org/10.1093/jac/dkh353
39. Burton PJ, Thornsberry C, Cheung YY, Watts JL, Yancey RJ. Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease. J Vet Diagn Invest. 1996; 8:464-8. http://dx.doi.org/10.1177/104063879600800411
40. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother. 2001; 45:2716-22. http://dx.doi.org/10.1128/AAC.45.10.2716-2722.2001